New chronic heart failure guidance: what does it mean for practice?

In this episode of The PJ Pod, we explore the main changes and implications for practice of the National Institute for Health and Care Excellence (NICE)’s chronic heart failure guidance update. On 3 September 2025, NICE released its updated guidance on ‘Chronic heart failure in adults: diagnosis and management’. The guidance mentions the role of pharmacy for the first time and has implications for an expanded role for primary care in managing heart failure. The guidance makes several recommendations, including on the use of combination treatment of the four main types of treatment: angiotensin-converting enzyme inhibitors (ACEIs), beta-blockers (BBs), mineralocorticoid receptor antagonists (MRAs) and sodium-glucose co-transporter-2s (SGLT2s) inhibitors — also known as the four pillars — in the early treatment of heart failure. In this episode of The PJ Pod, clinical editor Caitlin Killen talks to Paul Wright, consultant cardiovascular pharmacist at Barts Health NHS Trust, to learn more about the guidance and its implications for practice. This episode was produced by Geoff Marsh.

You can listen to New chronic heart failure guidance: what does it mean for practice? online on Radio and Podcast. Open the player on this page to stream the available audio.

New chronic heart failure guidance: what does it mean for practice? is an episode from The PJ Pod by The PJ Pod.

This episode is 00:15:38 long.

This episode was published on Nov 12, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from The PJ Pod when more episodes are available from the podcast feed.